Stay updated on Gevokizumab with Anti-cancer Therapies in Metastatic Cancers Clinical Trial
Sign up to get notified when there's something new on the Gevokizumab with Anti-cancer Therapies in Metastatic Cancers Clinical Trial page.

Latest updates to the Gevokizumab with Anti-cancer Therapies in Metastatic Cancers Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedSite updated to revision v3.4.2; the previous notice about lapse in government funding (v3.4.1) has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check23 days agoChange DetectedAdministrative updates: a government funding lapse notice with NIH Clinical Center open status and links, and a page revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check30 days agoChange DetectedLocations section updated: new sites added (Calgary, Kashiwa, Osaka, Seville, Tainan) and several existing locations removed or reformatted. Accompanying metadata such as Last Update and Revision notes were updated.SummaryDifference0.7%

- Check44 days agoChange DetectedAdded Revision: v3.3.4 and removed Revision: v3.3.3 in the page footer. This is a minor site version update with no changes to study content or outcomes.SummaryDifference0.0%

- Check66 days agoChange DetectedNew locations were added to the study record, expanding the geographic footprint of the trial. The additions cover sites in the United States (California, Missouri, Tennessee, Michigan), Australia (Victoria), Canada (Alberta, Ontario), Germany (Hesse, Saxony), Japan (Aichi-ken, Chiba, Osaka, Shizuoka, Tokyo), Spain (Andalusia, Barcelona).SummaryDifference1%

- Check88 days agoChange DetectedA minor version revision was applied (v3.3.2; v3.3.1 removed). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Gevokizumab with Anti-cancer Therapies in Metastatic Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Gevokizumab with Anti-cancer Therapies in Metastatic Cancers Clinical Trial page.